Equities researchers at StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD – Get Free Report) in a report issued on Wednesday. The firm set a “sell” rating on the medical equipment provider’s stock.
Aethlon Medical Stock Performance
AEMD opened at $0.37 on Wednesday. The company’s 50-day simple moving average is $0.41 and its two-hundred day simple moving average is $0.61. The stock has a market capitalization of $5.14 million, a P/E ratio of -0.08 and a beta of 1.74. Aethlon Medical has a 52-week low of $0.24 and a 52-week high of $2.35.
Aethlon Medical (NASDAQ:AEMD – Get Free Report) last issued its quarterly earnings data on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.44) by $0.10. During the same quarter in the prior year, the company posted ($1.30) EPS. Research analysts forecast that Aethlon Medical will post -1.1 EPS for the current fiscal year.
Aethlon Medical Company Profile
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
Further Reading
- Five stocks we like better than Aethlon Medical
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Short Selling: How to Short a Stock
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- What Are the U.K. Market Holidays? How to Invest and Trade
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
